EMvision Medical Devices Ltd.ASX: EMV

UCLA Health Activation & Continuous Innovation Study Update

· Issued by EMvision Medical Devices Ltd.

Filed with ASX · · 5 pages · English

Summary by 6ix AI

EMvision Medical Devices Ltd. provides an update on the UCLA Health activation and Continuous Innovation Study for its emu™ brain scanner device. The UCLA Health site is set to activate soon, completing the initiation of all trial sites for the pivotal study. The company is on track for its De Novo submission, with recruitment targets expected to be met in the first half of the upcoming year. Additionally, Box Hill Hospital has been added as a new site for the Continuous Innovation Study.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

EMvision Medical Devices Ltd. on 6ix

Story so far

Earlier from EMvision Medical Devices

Later from EMvision Medical Devices

All EMvision Medical Devices news releases